PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+3.67%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.47B
AUM Growth
+$2.47B
(-0.36%)
Cap. Flow
-$40.2M
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
64.01%
Holding
148
New
9
Increased
31
Reduced
65
Closed
14
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$136M |
| 2 |
Skyworks Solutions
SWKS
|
$95.6M |
| 3 |
Lamb Weston
LW
|
$61.3M |
| 4 |
Pinduoduo
PDD
|
$41.2M |
| 5 |
Flutter Entertainment
FLUT
|
$9.31M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$50.5M |
| 2 |
Micron Technology
MU
|
$41.4M |
| 3 |
ZTO Express
ZTO
|
$36.8M |
| 4 |
Ball Corp
BALL
|
$33.1M |
| 5 |
Intercontinental Exchange
ICE
|
$31M |
Sector Composition
| 1 | Technology | 23.38% |
| 2 | Consumer Discretionary | 15.08% |
| 3 | Energy | 14.69% |
| 4 | Industrials | 13.22% |
| 5 | Financials | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
TORM
TRMD
$2.21B
| $3.09M | 0.13% |
79,825
| – | – |
|
|
LBPH
52
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.08M | 0.12% |
114,047
-13,001
| -10% | -$351K |
|
53
Oracle
ORCL
$628B
| $3.07M | 0.12% |
21,762
| – | – |
|
54
Applied Materials
AMAT
$124B
| $2.98M | 0.12% |
12,616
| – | – |
|
55
Recursion Pharmaceuticals
RXRX
$2.02B
| $2.97M | 0.12% |
395,673
-1,404,796
| -78% | -$10.5M |
|
56
Lam Research
LRCX
$124B
| $2.88M | 0.12% |
2,705
| – | – |
|
57
Veeva Systems
VEEV
$44.4B
| $2.83M | 0.11% |
15,487
+1,873
| +14% | +$343K |
|
58
Wave Life Sciences
WVE
$1.27B
| $2.68M | 0.11% |
537,345
-62,810
| -10% | -$313K |
|
59
Esperion Therapeutics
ESPR
$490M
| $2.66M | 0.11% |
1,196,526
-401,016
| -25% | -$890K |
|
60
Immatics
IMTX
$662M
| $2.37M | 0.1% |
203,614
-85,075
| -29% | -$989K |
|
61
Arcus Biosciences
RCUS
$1.24B
| $2.34M | 0.09% |
153,783
-50,615
| -25% | -$771K |
|
62
Arrowhead Research
ARWR
$3.84B
| $2.3M | 0.09% |
88,425
-8,743
| -9% | -$227K |
|
63
Structure Therapeutics
GPCR
$1.14B
| $2.25M | 0.09% |
57,230
-19,863
| -26% | -$780K |
|
64
Moderna
MRNA
$9.36B
| $2.16M | 0.09% |
18,193
-5,380
| -23% | -$639K |
|
65
Analog Devices
ADI
$120B
| $2.1M | 0.08% |
9,196
+2,231
| +32% | +$509K |
|
66
AnaptysBio
ANAB
$630M
| $2.06M | 0.08% |
82,401
+16,247
| +25% | +$407K |
|
67
NXP Semiconductors
NXPI
$57.5B
| $1.85M | 0.07% |
6,866
| – | – |
|
68
Sarepta Therapeutics
SRPT
$1.98B
| $1.79M | 0.07% |
11,301
+1,026
| +10% | +$162K |
|
69
Qualcomm
QCOM
$170B
| $1.74M | 0.07% |
8,734
+2,098
| +32% | +$418K |
|
70
Texas Instruments
TXN
$178B
| $1.71M | 0.07% |
+8,815
| New | +$1.71M |
|
71
Absci
ABSI
$356M
| $1.63M | 0.07% |
530,682
-245,920
| -32% | -$757K |
|
72
Q32 Bio
QTTB
$20.9M
| $1.61M | 0.07% |
89,456
-20,508
| -19% | -$368K |
|
73
lululemon athletica
LULU
$23.8B
| $1.49M | 0.06% |
5,000
-2,000
| -29% | -$597K |
|
74
Bio-Techne
TECH
$8.3B
| $1.47M | 0.06% |
20,449
-2,375
| -10% | -$170K |
|
75
908 Devices
MASS
$199M
| $1.41M | 0.06% |
274,067
-98,233
| -26% | -$506K |
|